Amgen (NASDAQ:AMGN) Raised to “Strong-Buy” at StockNews.com

Amgen (NASDAQ:AMGN – Get Free Report) was upgraded by StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Friday. AMGN has been the subject of a number of other research reports. TD Cowen boosted their target price on Amgen from $381.00 to $383.00 and gave […]

Leave a Reply

Your email address will not be published.

Previous post Bishop Feehan defense gives St. Mary’s first loss
Next post UBS Group (NYSE:UBS) Raised to Buy at StockNews.com